-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Chengdu, September 29, 2021/PRNewswire/ - Rabies is a zoonotic disease that seriously endangers public health.
It is caused by rabies virus invading the central nervous system.
The case fatality rate is close to 100%
.
From a global perspective, about 59,000 people die from rabies each year, and 99% of human rabies cases are transmitted by dogs[1]
At the opening ceremony of Kanghua Animal Insurance (Chengdu) Biotechnology Co.
, Ltd.
(hereinafter referred to as "Kanghua Animal Insurance") held recently, Wang Zhentao, chairman of Chengdu Kanghua Bioproducts Co.
, Ltd.
, said that outstanding companies are often in line with the times.
For companies with high frequency resonance, it is important to choose the right track
.
With the advent of the era of great health and the outbreak of the new crown epidemic, the world has seen the strength of China's vaccines and the Chinese people have recognized the value of "Made in China"
Wang Zhentao, Chairman of Chengdu Kanghua Biological Products Co.
, Ltd.
Li Wei, general manager of Kanghua Animal Health, said that Kanghua Animal Health will provide consumers with high-quality pet products and services based on the concept of "a high-end pet diagnosis and treatment product provider, a high-quality partner for pet doctors and pet owners".
And is committed to preventing the front end of rabies-dogs
.
Li Wei, General Manager of Kanghua Animal Insurance
Kanghua Animal Insurance is a wholly-owned subsidiary of Chengdu Kanghua Biological Products Co.
, Ltd.
(stock code 300841, hereinafter referred to as "Kanghua Biological").
Kanghua Biological has broken the technical limitations of domestic rabies vaccines that have been using animal cells to prepare rabies vaccines.
, The existing human rabies prevention product "freeze-dried human rabies vaccine (HDCV)"
.
On the basis of the traditional human diploid cell seedling production technology, the company optimized the use of microcarrier culture technology and added concentration and purification steps
The ribbon-cutting ceremony of Kanghua Animal Insurance Opening Ceremony
On the day of the opening ceremony, Kanghua Animal Health also signed strategic cooperation agreements with Hangzhou Youben Animal Vaccine Co.
, Ltd.
and Niuqin Biotechnology (Shanghai) Co.
, Ltd.
to cooperate in the development of high-end pet rabies vaccines and pet cleaning and disinfection
.
In the subsequent "Big Coffee Roundtable" forum, experts and scholars in the field of small animal medicine from all over the country conducted intense discussions on topics such as pet epidemic prevention, talent training, and the future development of the industry
Professor Lin Degui, Chairman of the Small Animal Medicine Branch of the Chinese Society of Animal Husbandry and Veterinary Medicine, Mr.
Cai Xuepeng, President of the Chinese Veterinary Medicine Association, Professor Tu Changchun, a researcher at the Military Veterinary Research Institute, Mr.
Ma Shichun, a researcher at the China Center for Animal Disease Prevention and Control, and Cheng Anchun, Dean of the School of Veterinary Medicine, Sichuan Agricultural University Mr.
Wang Qinghan, general manager of Chengdu Kanghua Biological Products Co.
, Ltd.
and other guests attended the roundtable forum
.
"ZERO BY 30" Opportunities and challenges coexist
In 2015, the World Health Organization (WHO), together with the Food and Agriculture Organization of the United Nations (FAO), the World Organization for Animal Health (OIE) and the Global Alliance for Rabies Control (GARC), at the Global Rabies Conference held in Geneva, Switzerland, proposed "2030 "Previously eliminate human rabies deaths caused by dogs in the world" (abbreviation: ZERO BY 30) strategic goal
.
In order to achieve this goal, countries around the world have introduced various policies to reduce the damage caused by rabies to humans
At the roundtable forum, the experts collectively called on everyone to pay attention to the spread of rabies by dogs
.
Professor Lin Degui pointed out that to eliminate dog-transmitted rabies, the focus is on prevention
Professor Cai Xuepeng explained that our country has the largest amount of animal breeding.
The "White Paper on China's Pet Industry in 2020" shows that the number of pet dogs and cats in China has exceeded the 100 million mark, and it is still growing at a rate of 9%-10% every year.
Increase, therefore, strengthening animal immunity is the key to eliminating rabies
.
The newly revised "Animal Epidemic Prevention Law of the People's Republic of China" also places great emphasis on immunization, monitoring and early warning of animal diseases
.
From a legislative point of view, it is clearly stipulated that dogs raised by units and individuals shall be immunized with rabies vaccine on a regular basis in accordance with regulations
According to WHO's research, vaccinating dogs, cats and other animals is the most economical way to prevent rabies in humans, and the spread of rabies can be effectively prevented when the dog's immunization coverage reaches more than 70%
.
Professor Tu Changchun pointed out in his speech: “If we want to achieve success in rabies prevention and control, we must pay attention to two factors.
In this process, the requirements for the training of professional talents have also been continuously improved
.
Dean Cheng Anchun said that the cultivation of talents in veterinary medicine requires continuous integration with the needs of social production
.
The college also strongly supports excellent companies to intervene in advance, "so that students can seamlessly meet production needs after graduation
.
"
From industry to colleges and universities, from legislation to personnel training, all aspects of our efforts are to better control the source of infection in an all-round way, take precautions, and solve the rabies dilemma
.
"Human use + pet use" high-quality vaccines help promote immunity
How to better respond to the national rabies prevention and control plan and promote the progress of animal immunization, the key lies in the development and production of high-quality animal vaccines
.
At the round table, Mr.
Ma Shichun expressed his expectation for animal vaccines, which is the foundation of pet epidemic prevention.
He pointed out: “The country will ultimately rely on enterprises to produce high-quality animal vaccines to help the country assume its social responsibility for eradicating rabies
.
From From this perspective, our animal vaccines must be more scientific and advanced to occupy the mid-to-high-end market
.
"
"At present, there are very few domestic companies producing high-end rabies vaccines
.
" Professor Cai Xuepeng added, "In the future, China will definitely become the largest market for pet animal protection products, and technological innovation is the driving force behind the development of vaccine manufacturers
.
"
Mr.
Wang Qinghan, general manager of Kanghua Biology, said that the two ends of rabies prevention are humans and animals.
The key to reducing human rabies is to prevent and control dog epidemics
.
Kanghua Biology has been paying attention to the prevention of human rabies since 2004, and the official opening of Kanghua Animal Health signifies that Kanghua Biology has begun to work hard to control the source of infection and establish the dog’s immune barrier, and then through the use of humans and Pets use two aspects to help the "ZERO BY 30" goal, so that more people will benefit
.
According to statistics, in 2014, Kanghua Biological’s human diploid cell rabies vaccine (HDCV) was approved for marketing.
So far, it has been sold more than 10 million times, providing protection for more than 2 million people, and opening up China’s domestic rabies vaccine The new era of "human resources"
.
HDCV has obvious advantages in terms of immune effect and speed of onset.
The duration of immunity can be up to 10 years.
The incidence of adverse reactions is less than 1%.
It is suitable for the whole population (including children, the elderly and pregnant women).
Standard" vaccine
.
This time, Kanghua Animal Protection combines the advantages of the human vaccine production process and cooperates with Hangzhou Youben Bio to produce high-quality animal vaccines with high safety, immunogenicity, immunity persistence, quality controllability and accessibility
.
Through independent research and development and production of domestic high-quality pet vaccines, we will make unremitting efforts to open up the "last mile" of rabies prevention
.
In the future, Kanghua Animal Health will also work with Kanghua Bio to strengthen the prevention and control of rabies, work hard to eliminate rabies in China, and witness the arrival of "ZERO BY 30" and the arrival of the era of harmonious coexistence between humans and pets
.
[1] Emergency Physician Branch of Chinese Medical Doctor Association, Chinese People's Liberation Army Emergency Medicine Committee, Beijing Association of Emergency Medicine, etc.
Expert consensus on emergency treatment of dog bites in China (2019)[J].
Chinese Emergency Medicine, 2019, 39(9) .
[2] Zhu Zijie, Li Jianli, Wang Heping, et al.
The prevalence of rabies and its immune prevention and control[J].
Veterinary Guide, 2010, 000(004): 66-67.
Source: Kanghua Animal Insurance Company
